Registro:

Referencias:

• Abdel-Haq, H., Giacomelli, S., Palmery, M., Leone, M.G., Saso, L., Silvestrini, B., Aflatoxins inhibit prolactin secretion by rat pituitary cells in culture (2000) Drug and Chemical Toxicology, 23, pp. 381-386
• Asa, S.L., Ezzat, S., The pathogenesis of pituitary tumors (2009) Annual Review of Pathology, 4, pp. 97-126
• Bae, M.K., Kim, S.H., Jeong, J.W., Lee, Y.M., Kim, H.S., Kim, S.R., Yun, I., Kim, K.W., Curcumin inhibits hypoxia-induced angiogenesis via down- regulation of HIF-1 (2006) Oncology Reports, 15, pp. 1557-1562
• Bangaru, M.L., Woodliff, J., Raff, H., Kansra, S., Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease (2010) PLoS ONE, 5, pp. e9893
• Bradford, M.M., A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Analytical Biochemistry, 72, pp. 248-254
• Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., Stalla, G.K., Holsboer, F., Arzt, E., RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1α during hypoxia (2007) Cell, 131, pp. 309-323
• Carmeliet, P., Angiogenesis in health and disease (2003) Nature Medicine, 9, pp. 653-660
• Carmeliet, P., VEGF as a key mediator of angiogenesis in cancer (2005) Oncology, 69, pp. 4-10
• Choi, H., Chun, Y.S., Kim, S.W., Kim, M.S., Park, J.W., Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition (2006) Molecular Pharmacology, 70, pp. 1664-1671
• Colao, A., Savastano, S., Medical treatment of prolactinomas (2011) Nature Reviews. Endocrinology, 7, pp. 267-278
• Ebert, B.L., Bunn, H.F., Regulation of the erythropoietin gene (1999) Blood, 94, pp. 1864-1877
• Farnoud, M.R., Kujas, M., Derome, P., Racadot, J., Peillon, F., Li, J.Y., Interactions between normal and tumoral tissues at the boundary of human pituitary adenomas (1994) Virchows Archiv: an International Journal of Pathology, 424, pp. 75-82
• Ferrara, N., Vascular endothelial growth factor: basic science and clinical progress (2004) Endocrine Reviews, 25, pp. 581-611
• Giustina, A., Bronstein, M.D., Casanueva, F.F., Chanson, P., Ghigo, E., Ho, K.K., Klibanski, A., Melmed, S., Current management practices for acromegaly: an international survey (2011) Pituitary, 14, pp. 125-133
• Gloddek, J., Pagotto, U., Paez-Pereda, M., Arzt, E., Stalla, G.K., Renner, U., Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells (1999) Journal of Endocrinology, 160, pp. 483-490
• Gospodarowicz, D., Abraham, J.A., Schilling, J., Isolation and characterization of a vascular cell mitogen produced by pituitary-derived folliculo stellate cells (1989) PNAS, 6, pp. 7311-7315
• Gupta, S.C., Kim, J.H., Prasad, S., Aggarwal, B.B., Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals (2010) Cancer and Metastasis Reviews, 29, pp. 405-434
• Gupta, S.C., Prasad, S., Kim, J.H., Patchva, S., Webb, L.J., Priyardasini, I.K., Aggarwal, B.B., Multitargeting by curcumin as revealed by molecular interaction studies (2011) Natural Product Reports, 28, pp. 1937-1955
• Harris, A.L., Hypoxia - a key regulatory factor in tumour growth (2002) Nature Reviews. Cancer, 2, pp. 38-47
• Hickey, M.M., Simon, M.C., Regulation of angiogenesis by hypoxia and hypoxia-inducible factors (2006) Current Topics in Developmental Biology, 76, pp. 217-257
• Hori, S., Hayashi, N., Fukuoda, J., Kurimoto, M., Hamada, H., Miyajima, K., Nagai, S., Endo, S., Folliculostellate cell tumor in the pituitary gland (2009) Neuropathology, 29, pp. 78-80
• Iwaki, T., Kondo, A., Takeshita, I., Nakagaki, H., Kitamura, K., Tateishi, J., Proliferating potential of folliculo-stellate cells in human pituitary adenomas, Immunohistochemical and electron microscopic analysis (1986) Acta Neuropathologica, 71, pp. 233-242
• Jung, H.J., Kim, J.H., Shim, J.S., Kwon, H.J., A novel Ca2C/calmodulin antagonist HBC inhibits angiogenesis and down-regulates hypoxia-inducible factor (2010) Journal of Biological Chemistry, 285, pp. 25867-25874
• Kim, K., Yoshida, D., Teramoto, A., Expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in pituitary adenomas (2005) Endocrine Pathology, 16, pp. 115-121
• Kunnumakkara, A.B., Anand, P., Aggarwal, B.B., Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins (2008) Cancer Letters, 269, pp. 199-225
• Lafont, C., Desarmenien, M.G., Cassou, M., Molino, F., Lecoq, J., Hodson, D., Lacampagne, A., Carmignac, D., Cellular in vivo imaging reveals coordinated regulation of pituitary microcirculation and GH cell network function (2010) PNAS, 107, pp. 4465-4470
• Lloyd, R.V., Scheithauer, B.W., Kuroki, T., Vidal, S., Kovacs, K., Stefaneanu, L., Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas (1999) Endocrine Pathology, 10, pp. 229-235
• Lohrer, P., Gloddek, J., Hopfner, U., Losa, M., Uhl, E., Pagotto, U., Stalla, G.K., Renner, U., Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro (2001) Neuroendocrinology, 7, pp. 95-105
• Masson, N., Ratcliffe, P.J., HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels (2003) Journal of Cell Science, 116, pp. 3041-3049
• Melmed, S., Pathogenesis of pituitary tumors (2011) Nature Reviews. Endocrinology, 7, pp. 257-266
• Miller, M., Chen, S., Woodliff, J., Kansra, S., Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells (2008) Endocrinology, 149, pp. 4158-4167
• Nagasawa, H., The in vitro and in vivo effects of dimethyl sulfoxide on the pituitary secretion of growth hormone and prolactin in mice (1983) Annals of the New York Academy of Sciences, 411, pp. 34-42
• Onofri, C., Theodoropoulou, M., Losa, M., Uhl, E., Lange, M., Arzt, E., Stalla, G.K., Renner, U., Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours (2006) Journal of Endocrinology, 191, pp. 249-261
• Pagotto, U., Arzberger, T., Theodoropoulou, M., Grübler, Y., Pantaloni, C., Saeger, W., Losa, M., Spengler, D., The expression of the antiproliferative gene ZAC is lost or highly reduced in non-functioning pituitary adenomas (2000) Cancer Research, 60, pp. 6794-6799
• Perez-Castro, C., Renner, U., Haedo, M.R., Stalla, G.K., Arzt, E., Cellular and molecular specificity of pituitary gland physiology (2012) Physiological Reviews, 92, pp. 1-38
• Raverot, G., Sturm, N., de Fraipont, F., Muller, M., Salenave, S., Caron, P., Chabre, O., Assaker, R., Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience (2010) Journal of Clinical Endocrinology and Metabolism, 95, pp. 4592-4599
• Renner, U., Arzberger, T., Pagotto, U., Leingruber, S., Uhl, E., Müller, A., Lange, M., Stalla, G.K., Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically non-functioning pituitary adenomas (1998) Journal of Clinical Endocrinology and Metabolism, 83, pp. 1368-1375
• Renner, U., Lohrer, P., Schaaf, L., Feirer, M., Schmitt, K., Onofri, C., Arzt, E., Stalla, G.K., Transforming growth factor-β stimulates vascular endothelial growth factor production by folliculostellate pituitary cells (2002) Endocrinology, 143, pp. 3759-3765
• Renner, U., Paez-Pereda, M., Arzt, E., Stalla, G.K., Growth factors and cytokines: function and molecular regulation in pituitary adenomas (2004) Frontiers of Hormone Research, 32, pp. 96-109
• Saeger, W., Lüdecke, D.K., Buchfelder, M., Fahlbusch, R., Quabbe, H.J., Petersenn, S., Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry (2007) European Journal of Endocrinology, 156, pp. 203-216
• Santos, N.C., Figueira-Coelho, J., Martins-Silva, J., Saldanha, C., Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects (2003) Biochemical Pharmacology, 65, pp. 1035-1041
• Schaaf, C., Shan, B., Buchfelder, M., Losa, M., Kreutzer, J., Rachinger, W., Stalla, G.K., Perone, M.J., Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo (2009) Endocrine-Related Cancer, 16, pp. 1339-1350
• Schaaf, C., Shan, B., Onofri, C., Stalla, G.K., Arzt, E., Schilling, T., Perone, M.J., Renner, U., Curcumin inhibits the growth, induces apoptosis and modulates the function of pituitary folliculostellate cells (2010) Neuroendocrinology, 91, pp. 200-210
• Shahani, K., Swaminathan, S.K., Freeman, D., Blum, A., Ma, L., Panyam, J., Injectable sustained release microparticles of curcumin: a new concept for cancer prevention (2010) Cancer Research, 70, pp. 4443-4452
• Shan, B., Gerez, J., Haedo, M., Fuertes, M., Theodoropoulou, M., Buchfelder, M., Losa, M., Renner, U., RSUME is implicated in HIF-1-induced VEGFA production in pituitary tumour cells (2012) Endocrine-Related Cancer, 19, pp. 13-27
• Shehzad, A., Wahid, F., Lee, Y.S., Curcumin in cancer prevention: molecular targets, pharmacokinetics, bioavailability, and clinical targets (2010) Archiv der Pharmazie, 9, pp. 489-499
• Shih, S.C., Claffey, K.P., Role of AP-1 and HIF-1 transcription factors in TGF-β activation of VEGF expression (2001) Growth Factors, 19, pp. 19-34
• Ströfer, M., Jelkmann, W., Depping, R., Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells (2011) The role of HIF. Strahlentherapie und Onkologie, 187, pp. 393-400
• Thomas, S.L., Zhong, D., Zhou, W., Malik, S., Liotta, D., Snyder, J.P., Hamel, E., Giannakakou, P., EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1 (2008) Cell Cycle, 7, pp. 2409-2417
• Turner, H.E., Nagy, Z., Gatter, K.C., Esiri, M.M., Harris, A.L., Wass, J., Angiogenesis in pituitary adenomas and the normal pituitary gland (2000) Journal of Clinical Endocrinology and Metabolism, 85, pp. 1159-1162
• Viacava, P., Gasperi, M., Acerbi, G., Manetti, L., Cecconi, E., Bonadio, A.G., Naccarato, A.G., Lupi, I., Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas (2003) Journal of Endocrinological Investigation, 26, pp. 23-28
• Vidal, S., Horvath, E., Kovacs, K., Kuroki, T., Lloyd, R.V., Scheithauer, B.W., Expression of hypoxia-inducible factor-1α (HIF-1α) in pituitary tumours (2003) Histology and Histopathology, 18, pp. 679-686
• Wahl, O., Oswald, M., Tretzel, L., Herres, E., Arend, J., Efferth, T., Inhibition of tumor angiogenesis by antibodies, synthetic small molecules and natural products (2011) Current Medicinal Chemistry, 18, pp. 3136-3155
• Webb, J.D., Coleman, M.L., Pugh, C.W., Hypoxia, hypoxia-inducible factors (HIF) (2009) HIF hydroxylases and oxygen sensing. Cellular and Molecular Life Sciences, 66, pp. 3539-3554
• Wei, W., Yu, X.D., Hypoxia-inducible factors: cross-talk between their protein stability and protein degradation (2007) Cancer Letters, 257, pp. 145-156
• Yadav, V.R., Aggarwal, B.B., Curcumin: a component of the golden spice, targets multiple angiogenic pathways (2011) Cancer Biology & Therapy, 11, pp. 236-241
• Yuan, Y., Hilliard, G., Ferguson, T., Millhorn, D.E., Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α (2003) Journal of Biological Chemistry, 278, pp. 15911-15916

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------